Bruker Corporation announced the addition of Jack J. Phillips to its Board of Directors.
Mr. Phillips brings over 30 years of leadership experience in the diagnostics industry.
His expertise in translating scientific innovations into clinical impact will benefit Bruker's strategic growth.
Leadership Experience
Jack Phillips has a strong background in the diagnostics industry, previously serving as President & CEO of Accelerate Diagnostics and Roche Diagnostics.
Strategic Acumen
His addition to Bruker's board will enhance market development strategies and accelerate business growth in diagnostics.
Innovative Portfolio
Bruker aims to broaden its infectious disease diagnostics portfolio and leverage disease biology research tools for specialty diagnostics.
- Jack Phillips' appointment reflects Bruker's commitment to innovation and clinical translation in the diagnostics field.
- His experience in advancing innovation for patient benefit aligns with Bruker's focus on post-genomic discoveries.
The collaboration between Jack J. Phillips and Bruker Corporation is expected to drive further advancements in diagnostics and strengthen the company's position in the healthcare industry.